<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab5">
 <label>Table 5</label>
 <caption>
  <p>Conditioning and outcome after transplant</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>≤ 65 years old</th>
    <th>ASCT &gt; 65 years old</th>
    <th>No ASCT ≥ 65 years old</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="4">Conditioning</td>
   </tr>
   <tr>
    <td> MEL200 (
     <italic>n</italic>)
    </td>
    <td>101 (98%)</td>
    <td>11 (38%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> MEL140 (
     <italic>n</italic>)
    </td>
    <td>2 (2%)</td>
    <td>15 (52%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> MEL100 (
     <italic>n</italic>)
    </td>
    <td>0</td>
    <td>3 (10%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td colspan="4">Response at day 100</td>
   </tr>
   <tr>
    <td> CR (%)</td>
    <td>50 (49%)</td>
    <td>17 (59%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> VGPR (%)</td>
    <td>39 (38%)</td>
    <td>6 (21%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> PR (%)</td>
    <td>10 (9%)</td>
    <td>4 (14%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> Refractory/stable (%)</td>
    <td>1 (1%)</td>
    <td>0</td>
    <td>NA</td>
   </tr>
   <tr>
    <td> Death at day 100 (%)</td>
    <td>3 (3%)</td>
    <td>2 (6%)</td>
    <td>NA</td>
   </tr>
   <tr>
    <td>Mortality (
     <italic>n</italic>)
    </td>
    <td>21 (19%)</td>
    <td>10 (34%)</td>
    <td>13 (56%)</td>
   </tr>
   <tr>
    <td> MM progression (
     <italic>n</italic>)
    </td>
    <td>20</td>
    <td>7</td>
    <td>9</td>
   </tr>
   <tr>
    <td> Non-MM related (
     <italic>n</italic>)
    </td>
    <td>1</td>
    <td>3</td>
    <td>4</td>
   </tr>
   <tr>
    <td colspan="4">Disease status at last follow-up</td>
   </tr>
   <tr>
    <td> CR (
     <italic>n</italic>)
    </td>
    <td>40 (49%)</td>
    <td>13 (68%)</td>
    <td>2 (20%)</td>
   </tr>
   <tr>
    <td> VGPR (
     <italic>n</italic>)
    </td>
    <td>23 (28%)</td>
    <td>2 (11%)</td>
    <td>1 (10%)</td>
   </tr>
   <tr>
    <td> PR (
     <italic>n</italic>)
    </td>
    <td>5 (6%)</td>
    <td>3 (16%)</td>
    <td>1 (10%)</td>
   </tr>
   <tr>
    <td> Refractory/stable (
     <italic>n</italic>)
    </td>
    <td>14 (17%)</td>
    <td>1 (5%)</td>
    <td>6 (60%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Three patients over 65 years had MEL100 as conditioning regimen: one patient for maintaining renal insufficiency after induction therapy; one patient for reduced number of cells for infusion (1.6 × 10
   <sup>6</sup> CD34+ cells/kg); and another patient for subjective evaluation of frailty. Two younger patients had conditioning with MEL140, both for persistent creatinine clearance ≤ 40 mL/min
  </p>
 </table-wrap-foot>
</table-wrap>
